Gerresheimer Insiders Pile In with €17.7M as Stakeholders Rush to Reshape the Register

Insiders and major stakeholders pour €17.7M into Gerresheimer shares as stock slumps 9% in a week, signaling deep conviction amid accounting probes and a 60% annual decline.

The gap between market sentiment and insider conviction at Gerresheimer has rarely been wider. While the stock slumped nearly 9% in a single week to close at €24.92 on Friday, a coalition of directors and allied investors has poured over €17.7 million into the shares. The buying spree signals that those closest to the company see value where the broader market sees only risk.

Two distinct stakeholder groups have moved in quick succession. Active Ownership, the investment vehicle controlled by Klaus Röhrig and Florian Schuhbauer, has lifted its effective holding to 16.85%. The figure breaks down into 13.67% in direct voting rights and roughly three percentage points via derivative instruments such as calls and puts. Separately, Röhrig is also a member of Gerresheimer’s supervisory board, a fact that makes the buying all the more telling.

That is not the only notable shift on the share register. The Goldman Sachs Group reported an aggregate voting-rights position of 20.09% as of 11 May 2026, up from 19.80% previously. Only 8.90% of that is tied to directly held shares; the remainder sits in financial instruments. Goldman’s move does not imply a strategic takeover intent, but it does signal that one of the world’s largest financial institutions considers the stock worth expanding into.

The insider buying is even sharper in focus. Company executives alone accounted for roughly €10 million in purchases last week, topping German insider-trading statistics. Then, on 12 May, AOC Gecko S.à r.l. — an entity closely tied to Klaus Röhrig — executed a block trade on Xetra worth €7,670,705.79 at €25.25 per share. Combined, the flow from management and Röhrig’s circle represents a vote of confidence rarely seen in such volume during a period of acute uncertainty.

That uncertainty is considerable. Gerresheimer is still working through accounting issues that have drawn scrutiny from BaFin, Germany’s financial regulator. The audited 2025 annual and consolidated financial statements are not expected before June 2026, and the company is simultaneously pushing ahead with the planned sale of its US subsidiary Centor Inc. These overhangs have hammered the share price: over twelve months the stock is down roughly 60% and sits far below its 52-week high of €64.40.

Yet the technical picture tells a more nuanced story. The stock now trades more than 18% above its 50-day moving average, and the relative strength index at 28 points to deeply oversold conditions. The combination of heavy insider support and a technically washed-out price often sets the stage for a turning point — but only if the €24 support zone holds. A break below that level could open the path toward the year’s low of €15.57.

Despite the weekly decline, the monthly perspective shows a 41% gain, suggesting the stock has already begun to claw back some of its earlier losses. The next major catalyst is the release of the audited financials in June. Until then, insider filings, stakeholder disclosures, and progress on the Centor sale are likely to drive the narrative far more than routine price action. For now, the message from those with the most skin in the game is unambiguous: buy the fear.